QUADRANT CAPITAL GROUP LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$7,000
+600.0%
435
+559.1%
0.00%
Q2 2022$1,000
-50.0%
66
-40.0%
0.00%
Q1 2022$2,000
-50.0%
110
-41.8%
0.00%
Q4 2021$4,000
+100.0%
189
+33.1%
0.00%
Q3 2021$2,000
-85.7%
142
-74.6%
0.00%
-100.0%
Q2 2021$14,000
+366.7%
560
+321.1%
0.00%
Q1 2021$3,000
-50.0%
133
+25.5%
0.00%
-100.0%
Q4 2020$6,000
+200.0%
106
+158.5%
0.00%
Q3 2020$2,000
-95.1%
41
-95.8%
0.00%
-100.0%
Q1 2020$41,000
-14.6%
968
-15.8%
0.01%
+16.7%
Q4 2019$48,000
+41.2%
1,149
+18.7%
0.01%
+20.0%
Q3 2019$34,000
+36.0%
9680.0%0.01%
+25.0%
Q2 2019$25,000
-62.7%
968
-58.7%
0.00%
-88.2%
Q4 2016$67,000
-17.3%
2,345
-9.1%
0.03%
-35.8%
Q3 2016$81,000
+1057.1%
2,581
+1022.2%
0.05%
+960.0%
Q2 2016$7,000
+16.7%
230
+28.5%
0.01%
+25.0%
Q4 2015$6,0001790.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders